RT-01

N/A

Report date: 2022/12/12 17:15:59

Base Information

Drug NameRT-01
Drug Alias NameOncolytic Virus Injection (RT-01)RT-01
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSolid tumoursUterine Cervical NeoplasmsEndometrial Neoplasms +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesWuxi People'S HospitalFirst Affiliated Hospital Bengbu Medical CollegeThe Affiliated Hospital Of Xuzhou Medical University
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Yunying Medical Technology Co LtdFirst Affiliated Hospital Bengbu Medical CollegeThe Affiliated Hospital Of Xuzhou Medical University
Inactive CompaniesWuxi People'S Hospital
Active IndicationsSolid tumoursUterine Cervical NeoplasmsEndometrial Neoplasms
Inactive IndicationsLymphoma, T-CellNeoplasmsVirus Diseases

Other Information

ATC CodeN/A
Related LinksN/A